Mehdi M. Moezi
Expertise in
44
conditions

Dr. Mehdi M. Moezi

Oncology
2370 Market Dr, 
Fleming Island, FL 
Accepting New Patients
Expertise in
44
conditions
2370 Market Dr, 
Fleming Island, FL 

Overview

Mehdi M. Moezi, MD, is an independent medical oncologist board-certified in medical oncology, hematology, and internal medicine at Ascension St. Vincent's in Fleming Island, Florida near Jacksonville, Florida.Originally from Iran, Dr. Moezi earned his Doctor of Medicine from the University of Tehran before completing his residency and fellowship programs in New York. He began his practice in 1990 at SUNY Downstate in Brooklyn New York, where he spent 10 years researching with some of the world’s leaders in lymphoma and myeloma. Dr. Moezi and his family settled in North Florida in 2001, when he began practicing at CSNF.

Dr. Moezi is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

Dr. Moezi is board certified in The American Board Of Internal Medicine - Medical Oncology and American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 4 clinical trials. Dr. Moezi is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in FL

Board Certifications

The American Board Of Internal Medicine - Medical Oncology
American Board Of Internal Medicine

Fellowships

Nassau County Medical Center / NY

Hospital Affiliations

Hca Florida Orange Park Hospital
Baptist Health Medical Center - Jacksonville
Ascension St Vincent's Clay County
Ascension St Vincent's Riverside
Ascension St. Vincent's Clay County Hospital
Ascension St. Vincent's Riverside Hospital
Ascension St. Vincent's St Johns County Hospital

Languages Spoken

English
Farsi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Cancer Specialists of North Florida - Market
2370 Market Dr, Fleming Island, FL 32003

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2025
Intervention Type: Drug
Study Drugs: Niraparib, Dostarlimab
Study Phase: Phase 3
A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors
A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase III, International, Randomized, Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent
A Phase III, International, Randomized, Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent
Enrollment Status: Terminated
Publish Date: September 26, 2022
Intervention Type: Drug
Study Drug: Rigosertib
Study Phase: Phase 3
A Phase 1/2 Study of Vadastuximab Talirine (SGN-CD33A) in Combination With Azacitidine in Patients With Previously Untreated International Prognostic Scoring System (IPSS) Intermediate-2 or High Risk Myelodysplastic Syndrome (MDS)
A Phase 1/2 Study of Vadastuximab Talirine (SGN-CD33A) in Combination With Azacitidine in Patients With Previously Untreated International Prognostic Scoring System (IPSS) Intermediate-2 or High Risk Myelodysplastic Syndrome (MDS)
Enrollment Status: Terminated
Publish Date: February 12, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

11 Total Publications

Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study.
Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study.
Journal: Cancer medicine
Published: March 24, 2025
Similar Doctors
Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required

FL - Cancer

4500 San Pablo Rd S, 
Jacksonville, FL 
 (20.6 miles away)
904-914-7532
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Thiel is an Oncologist practicing medicine in Jacksonville, Florida. Dr. Thiel is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Thiel is currently accepting new patients.

Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Mayo Clinic Hospital In Florida

4500 San Pablo Rd S, 
Jacksonville, FL 
 (20.6 miles away)
904-953-2000
Languages Spoken:
English

Kabir Mody is an Oncologist practicing medicine in Jacksonville, Florida. Dr. Mody is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Pancreaticoduodenectomy, and Tissue Biopsy.

Expertise in
7
conditions
Dr. Alvaro Moreno-Aspitia
Hematology | Oncology
Expertise in
7
conditions
Dr. Alvaro Moreno-Aspitia
Hematology | Oncology
Referral may be required

Mayo Clinic Hospital In Florida

4500 San Pablo Rd S, 
Jacksonville, FL 
 (20.6 miles away)
904-953-2000
Languages Spoken:
English
See accepted insurances

Alvaro Moreno-Aspitia is a Hematologist and an Oncologist practicing medicine in Jacksonville, Florida. Dr. Moreno-Aspitia is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Frequently Asked Questions about Dr. Mehdi M. Moezi

How do I make an appointment with Dr. Mehdi M. Moezi?

You can book an appointment with Dr. Mehdi M. Moezi by calling their office at 904-264-6201. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mehdi M. Moezi a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mehdi M. Moezi is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mehdi M. Moezi specialize in?

While Dr. Mehdi M. Moezi is a Oncology, they have specific expertise in Paget Disease of the Breast, Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Mehdi M. Moezi participate in research or clinical trials?

Yes. Dr. Mehdi M. Moezi has published 11 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Mehdi M. Moezi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mehdi M. Moezi accept my insurance?

Dr. Mehdi M. Moezi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 904-264-6201 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Moezi's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 36 Advanced Conditions
    View All 126 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile